April 12, 2022
Roche and Causaly Webinar: AI for smarter portfolio management
Insights from our talk at Biomarkers 2023: The use of human-centric AI in biomarker identification in Oncology and Immunology
Biomarkers 2023 was held in Manchester, UK on the 27th and 28th of February. The event brought together a diverse group of experts, across pharma, biotech, and academic institutions.
How LLMs like ChatGPT impact Causaly’s approach to biomedical knowledge discovery and acquisition
At Causaly, we stay close to the developments in the foundational natural language processing technologies and broader AI to understand where we stand with both academic and industrial state-of-the-art.
Why poor target validation is costing pharmaceutical businesses millions
It has been well documented that only 1 out of 10 compounds that enter clinical trials makes it to market¹. That is an astonishing 90% failure rate. It is hard to imagine hiring a lawyer or doctor or any professional who fails so often. Yet in our industry, it remains the norm.
Webinar – Knowledge discovery reimagined: finding new hypotheses with Causaly Cloud
Being able to stay up to date with scientific data and efficiently extracting insights is critical to drug R&D – but currently it is a manual, time-consuming process
Watch Causaly’s panel discussion from Discovery Europe
On June 9th – 10th 2022, over 400 pharma leaders came to Berlin to take part in Discovery Europe.